Keros Therapeutics, Inc. (KROS) Ownership

$15.94

north_east
$0.36 (2.31%)
Day's range
$15.61
Day's range
$16.37

Keros Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 5.39 M $85.26 M   0.00% 13.27%
VANGUARD GROUP INC 11/07/2025 2.72 M $43.01 M   3.31% 6.69%
BLACKROCK, INC. 11/12/2025 2.72 M $42.99 M   -0.57% 6.69%
MADISON AVENUE PARTNERS, LP 11/14/2025 2.71 M $42.84 M   0.62% 6.67%
WESTERN STANDARD LLC 11/12/2025 2.19 M $34.64 M   42.67% 5.39%
TANG CAPITAL MANAGEMENT LLC 11/14/2025 1.42 M $22.45 M   0.00% 3.49%
D. E. SHAW & CO., INC. 11/14/2025 1.33 M $21.06 M   2.62% 3.28%
GOLDMAN SACHS GROUP INC 11/14/2025 1.33 M $20.97 M   50.02% 3.26%
STATE STREET CORP 11/14/2025 1.30 M $20.61 M   -5.87% 3.21%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 1.23 M $19.51 M   -23.91% 3.04%
ORBIMED ADVISORS LLC 11/14/2025 1.02 M $16.12 M   0.00% 2.51%
ALKEON CAPITAL MANAGEMENT LLC 11/14/2025 850.51 K $13.46 M   0.00% 2.09%
LOGOS GLOBAL MANAGEMENT LP 11/14/2025 850.00 K $13.45 M   -57.50% 2.09%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 837.36 K $13.25 M   0.97% 2.06%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/17/2025 607.09 K $9.60 M   15.78% 1.49%
REDMILE GROUP, LLC 11/14/2025 552.51 K $8.74 M   0.00% 1.36%
FEDERATED HERMES, INC. 11/03/2025 514.16 K $8.13 M   -21.39% 1.27%
MORGAN STANLEY 11/14/2025 395.10 K $6.25 M   -55.04% 0.97%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 335.15 K $5.30 M   26.14% 0.83%
PDT PARTNERS, LLC 11/17/2025 332.82 K $5.27 M   0.00% 0.82%
NORTHERN TRUST CORP 11/14/2025 332.76 K $5.26 M   21.83% 0.82%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 303.12 K $4.80 M   683.73% 0.75%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 292.01 K $4.62 M   3.04% 0.72%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 11/13/2025 258.75 K $4.09 M   300.67% 0.64%
RANGELEY CAPITAL, LLC 11/14/2025 258.62 K $4.09 M   -9.38% 0.64%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 257.52 K $4.07 M   154.22% 0.63%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 250.00 K $3.96 M   0.00% 0.62%
CANADA PENSION PLAN INVESTMENT BOARD 11/13/2025 227.30 K $3.60 M   -28.61% 0.56%
BANK OF AMERICA CORP /DE/ 11/14/2025 226.13 K $3.58 M   -23.47% 0.56%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 217.50 K $3.44 M   -49.94% 0.54%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 216.70 K $3.43 M   90.65% 0.53%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 204.35 K $3.23 M   189.24% 0.50%
MAN GROUP PLC 11/14/2025 192.85 K $3.05 M   58.67% 0.47%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 189.20 K $2.99 M   -75.06% 0.47%
CITADEL ADVISORS LLC 11/14/2025 176.14 K $2.79 M   669.26% 0.43%
JPMORGAN CHASE & CO 11/26/2025 171.94 K $2.72 M   260.81% 0.42%
JANE STREET GROUP, LLC 11/14/2025 162.46 K $2.57 M   183.61% 0.40%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 154.70 K $2.45 M   5.53% 0.38%
RBF CAPITAL, LLC 11/14/2025 150.00 K $2.37 M   0.00% 0.37%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2025 121.53 K $1.92 M   100.00% 0.30%
AMERIPRISE FINANCIAL INC 11/14/2025 120.43 K $1.91 M   22.09% 0.30%
BANK OF NEW YORK MELLON CORP 11/03/2025 110.88 K $1.75 M   1.40% 0.27%
MONIMUS CAPITAL MANAGEMENT, LP 11/14/2025 108.05 K $1.71 M   19.53% 0.27%
UBS GROUP AG 11/13/2025 103.86 K $1.64 M   1.06% 0.26%
FMR LLC 11/13/2025 100.53 K $1.59 M   -38.80% 0.25%
SQUAREPOINT OPS LLC 11/14/2025 100.14 K $1.58 M   100.00% 0.25%
BARCLAYS PLC 11/12/2025 99.10 K $1.57 M   -18.19% 0.24%
SUPERSTRING CAPITAL MANAGEMENT LP 11/14/2025 95.08 K $1.50 M   100.00% 0.23%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 93.04 K $1.47 M   50.69% 0.23%
FRANKLIN RESOURCES INC 11/13/2025 87.76 K $1.39 M   -33.67% 0.22%

Keros Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 181 institutional investors and hedge funds held shares of Keros Therapeutics, Inc.. The most heavily invested institutionals were:

ADAR1 Capital Management, LLC: 5.39 M

VANGUARD GROUP INC: 2.72 M

BlackRock, Inc.: 2.72 M

Madison Avenue Partners, LP: 2.71 M

Western Standard LLC: 2.19 M

TANG CAPITAL MANAGEMENT LLC: 1.42 M

86.91% of Keros Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 38.50 M shares in the last 24 months. This purchase volume represents approximately $613.68 M in transactions.